pharmaceutical-market
Metsera Falls After Accepting up to $10 Billion Offer From Pfizer
Novo Nordisk Says Metsera Bid Won't Raise Antitrust Issues
Roche Shares Fall as New Drug Sales Disappoint
Novo Nordisk Hires US Pharma Veteran as Trump Pricing Pressure Mounts
Novo, Lilly's Shares Drop as Trump Vows Weight-Loss Drug Price Cuts
Date: October 17, 2025
COPENHAGEN (Reuters) -Novo Nordisk's shares fell 5.6% in early trade on Friday after U.S. President Donald Trump said on Thursday that the price of the Danish drugmaker's best-selling weight-loss drug...
Chemicals Maker Croda Warns of Tough Trading as US Tariffs Pressure Customers
Date: October 16, 2025
(Reuters) -British specialty chemicals maker Croda International flagged on Thursday a continued challenging trading environment for the rest of the year as U.S. tariffs were hurting exports of its...
Banquets and Billions: How AstraZeneca Sealed a US Medicine Deal With Trump
Date: October 12, 2025
By Maggie Fick LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices...
Eu, Japan Trust They Have Secured Limits to US Drug Tariffs
Date: September 26, 2025
BRUSSELS (Reuters) -The European Union and Japan expressed confidence on Friday that they had secured limits on U.S. tariffs on pharmaceuticals, which President Donald Trump said he would impose next...
Roche, Novartis Underline U.S. Plans After Trump Pharma Tariff Announcement
Date: September 26, 2025
ZURICH (Reuters) -Switzerland's Roche on Friday pointed to the fact that one of its U.S. units broke ground on a new facility in August and that the pharma company had pledged major U.S. investments...
European Pharma Shares Drop After Trump Threatens More Tariffs
Date: September 26, 2025
LONDON (Reuters) -Shares in Europe's biggest pharma companies fell in early trading on Friday, after U.S. President Donald Trump unveiled a new round of punishing tariffs, including 100% duties on...